Role of triglyceride-rich lipoproteins in diabetic nephropathy.
about
Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic PatientsA systematic review and meta-analysis of genetic association studies for the role of inflammation and the immune system in diabetic nephropathy.Parameter adaptations during phenotype transitions in progressive diseases.Obesity in kidney disease: A heavyweight opponent.Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetesPlasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.The association of maximum body weight on the development of type 2 diabetes and microvascular complications: MAXWEL study.Drug-related problems in type 2 diabetes mellitus patients with dyslipidemiaMultiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?Obesity, metabolic syndrome and diabetic nephropathyFive-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES StudyHuman apolipoprotein B transgenic SHR/NDmcr-cp rats show exacerbated kidney dysfunctionMicrovascular Complications and Their Associated Risk Factors in Newly Diagnosed Type 2 Diabetes Mellitus Patients.Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model.FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity.Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.Association of Postbreakfast Triglyceride and Visit-to-Visit Annual Variation of Fasting Plasma Glucose with Progression of Diabetic Nephropathy in Patients with Type 2 DiabetesNew therapeutic agents in diabetic nephropathy.Postprandial VLDL lipolysis products increase monocyte adhesion and lipid droplet formation via activation of ERK2 and NFκB.Postmeal triglyceridemia and variability of HbA1c and postmeal glycemia were predictors of annual decline in estimated glomerular filtration rate in type 2 diabetic patients with different stages of nephropathy.Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy.Smoking in diabetic nephropathy: sparks in the fuel tank?Fenofibrate and the kidney: an overview.Treatment and impact of dyslipidemia in diabetic nephropathy.Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes.Prediction of drug-related problems in diabetic outpatients in a number of hospitals, using a modeling approach.Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetesRole of triglyceride-rich lipoproteins in renal injury.Effect of edaravone in diabetes mellitus-induced nephropathy in rats.Metabolic imaging of fatty kidney in diabesity: validation and dietary intervention.A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model.Fasting APO B48 levels are associated with microalbuminuria in patients with type 2 diabetes.Antidiabetic effect of the total polyphenolic acids fraction from Salvia miltiorrhiza Bunge in diabetic rats.Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice.
P2860
Q30407920-9146EA73-689C-49EC-B962-A01E04C01E0FQ30992797-2D9A889C-C383-4697-B19D-46636ADCD0D0Q33783045-9363283F-7215-41EB-B23B-7EF8D967D9DFQ34059056-B579F99F-DE2C-4B14-846A-DA754E1FDAA0Q34367664-A87E284A-1460-4AE8-8A41-52E2087BE077Q34427292-3D541FBA-8ABF-4252-9EEE-5C22C3E41D1FQ34718616-8E8A13F5-220A-4821-92A3-6926FA1B824DQ35063749-9C8289EC-714A-445B-BE53-12C1AD092899Q35068358-DB68A728-EFE6-45E9-9CAD-A089AA5E8038Q35126070-E800EB22-7AD0-4E01-A6C8-1C306E47F6C5Q35183612-F1036087-6AB6-4D36-B498-A57DB2DB3C2FQ35224446-C966FD96-D601-487A-9F42-E50039E6659DQ35344925-4B27980B-AD17-4A9A-9144-4E1A8CD33B01Q35992007-96C16425-8E9D-411C-BF97-771A555C53D8Q36112535-E44941B7-01A8-4421-AD6E-B3936EDCD2A6Q36179961-D1829C4D-E2E8-4A2E-BC65-854D5FF0D89DQ36294501-69F1B550-321F-4A19-BD26-4211594DB885Q36345943-DC935E91-6F14-4E45-B0FF-B777758630AEQ37448563-C461E30E-D982-4D1D-9E31-B8503602159AQ37559164-D73647C9-3593-4072-96FD-A010955D1953Q37575951-4C773229-259C-46C8-8DAD-6EF8D8EBC6B3Q37578952-B779ED08-0A72-40A7-A2FE-88875C4BF04CQ37603244-6FAB07FD-5BB1-41DA-ADD9-611BE52257A6Q38072702-542B5FB9-5E61-45FA-BA7F-E530C3C1B76FQ38088377-BFDAD179-D693-4425-9B96-6798D1189D93Q38160397-4919E904-C63C-48AE-A548-327E89F9FB29Q38160494-BBFA7A53-367C-46B8-B23F-56EF39F0B872Q40232094-D3C51878-A40F-4FAF-AD97-727D0D7719BCQ41123351-31A7B9F7-D322-4269-900F-B6DF2DDF2DBCQ41283460-89BBB6DC-F35B-45DE-BDEE-AF2DF824AEACQ41846923-8B80D0E6-6633-4473-82F5-17DE6EC1C087Q42223823-B4AFE1C6-050A-4695-97BF-67C6F28B218BQ42434867-0438DD49-6A79-4BA8-BBF0-5DC5B12AF6B1Q47676923-56690CC4-3366-4207-AA0E-9AB468E70719Q48100272-2CB46C74-EB1E-4B62-87E2-060D2A9B8BBEQ51359468-74EA5FE9-BF72-4874-B641-2729BF278BCFQ51365152-45BEEEBA-50D9-4E92-9E6C-25DB80E77442Q52728405-C96BEFBA-AD9F-46A4-B0AC-84FC96E24733Q54373570-861B8A16-5563-4224-BCC4-500992C79244Q55234574-E4B5C20C-C1F0-40FA-8D52-86605C277CF0
P2860
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@en
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@nl
type
label
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@en
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@nl
prefLabel
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@en
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@nl
P2093
P2860
P356
P1476
Role of triglyceride-rich lipoproteins in diabetic nephropathy.
@en
P2093
Dennis W Wilson
Hnin H Aung
John C Rutledge
P2860
P2888
P304
P356
10.1038/NRNEPH.2010.59
P407
P577
2010-05-04T00:00:00Z